Professor Stephen Jackson gives presentation at ESSTS (European Society for the Study of Tourette Syndrome)

June 13, 2023

Professor Stephen Jackson captivated the audience on the final day of the European Society for the Study of Tourette Syndrome (ESSTS) conference with a presentation on the clinical trial results of the Neupulse device in Tourette Syndrome.

During his talk, Professor Jackson gave the background into using the peripheral nervous system to stimulate the brain to reduce the urge to tic and tic frequency. He provided a comprehensive overview of the findings from the groundbreaking clinical trial, which were recently published in the prestigious Journal of Neuropsychology in May 2023. This exciting breakthrough science underpins the work and product development at Neupulse.

Company number: 13198315 

Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road

Privacy Notice       Cookies

Neupulse and Neutrack are registered trade marks of Neurotherapeutics Ltd

Website by Clifton Media

Tourettes Friendly Organisation
All members of the Neurotherapeutics team have completed training with Tourettes Action educating them about Tourettes Syndrome, thus have been awarded with the Tourettes Friendly Organisation badge recognised by Tourettes Action.
Medilink Midlands Awards
Back to Top